Evaluation of faecal lactoferrin as a morbidity biomarker in Schistosoma mansoni infection. Elhadad H, Mohamed MA, Mohamed MM, Abdo S, et al. Trop Med Int Health 2022 Oct 20. doi: 10.1111/tmi.13826.

Read + Share

Amedeo Smart

Independent Medical Education

Elhadad H, Mohamed MA, Mohamed MM, Abdo S, et al. Evaluation of faecal lactoferrin as a morbidity biomarker in Schistosoma mansoni infection. Trop Med Int Health 2022 Oct 20. doi: 10.1111/tmi.13826.
PMID: 36264644